No connection

Search Results

CIMP

BEARISH
$25.55 Live
Chimera Investment Corporation · NYSE
$24.25 52W Range $25.6

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 25, 2026
Market cap
N/A
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
The deterministic health profile for CIMP is severely compromised, headlined by a Piotroski F-Score of 1/9, indicating critical financial weakness. This fundamental fragility is compounded by a total lack of dividend strength (0/100) and a heavily bearish technical trend (10/100). While the current price sits near its 52-week high, the underlying deterministic metrics suggest a lack of sustainable support. The absence of key valuation and growth data further increases the risk profile, making the asset highly speculative.

Key Strengths

Price is currently trading near its 52-week high ($25.55 vs $25.60)
Positive long-term price change (+4.6% over 5 years)
Short-term price stability over the last month (+4.3%)

Key Risks

Critical financial health failure indicated by Piotroski F-Score of 1/9
Extreme bearish technical trend (10/100)
Complete absence of dividend strength and payout reliability
Weak insider sentiment (40/100)
Severe lack of transparent fundamental data (P/E, Debt/Equity, Revenue growth all N/A)

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
12
Weak
Value
0
Future
10
Past
40
Health
11
Dividend
0
AI Verdict
High Risk / Fundamentally Weak
Key drivers: Piotroski F-Score of 1/9, Technical Trend of 10/100, Dividend Strength of 0/100
Confidence
90%
Value
0/100

Ref P/E, PEG, Graham Number

Positives
No standout positives identified.
Watchpoints
  • No Graham Number available
  • No P/E or P/B metrics provided to establish a value floor
Future
10/100

Ref Growth rates

Positives
  • Recent 1-month price uptick
Watchpoints
  • Bearish technical trend
  • No growth metrics provided
Past
40/100

Ref Historical trends

Positives
  • Consistent but marginal growth over 1Y, 3Y, and 5Y (+4.6%)
Watchpoints
  • Lack of significant momentum
Health
11/100

Ref Altman Z-Score, Piotroski F-Score

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score 1/9 indicates severe fundamental deterioration
Dividend
0/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend strength is 0/100

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$25.55

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CIMP and closest competitors.

Updated 2026-04-24
CIM
Chimera Investment Corporation
Primary
5Y
+4.6%
3Y
+4.6%
1Y
+4.6%
6M
+3.1%
1M
+4.3%
1W
+0.7%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
N/A
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

Past News Coverage

Recent headlines mentioning CIMP from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile